Repurposing of clinically proven bioactive compounds for targeted treatment of Alzheimer's disease using molecular docking approach.
In Silico Pharmacol
; 11(1): 33, 2023.
Article
in En
| MEDLINE
| ID: mdl-37920821
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
In Silico Pharmacol
Year:
2023
Document type:
Article
Country of publication:
Germany